title: Non-gastrointestinal malt lymphomas: a study of 10 cases and comparison with 27 patients with gastrointestinal MALT lymphoma.
authors.forename: J M
authors.initials: JM
authors.lastname: Sancho
authors.forename: J M
authors.initials: JM
authors.lastname: Ribera
authors.forename: M
authors.initials: M
authors.lastname: Vaquero
authors.forename: A
authors.initials: A
authors.lastname: Oriol
authors.forename: J A
authors.initials: JA
authors.lastname: Hernández-Rivas
authors.forename: E
authors.initials: E
authors.lastname: Feliu
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001774:Blood Chemical Analysis; D001943:Breast Neoplasms / Q000188:drug therapy; D003230:Conjunctival Neoplasms / Q000188:drug therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D018572:Disease-Free Survival; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010307:Parotid Neoplasms; D011239:Prednisolone / Q000008:administration & dosage; D011379:Prognosis; D015996:Survival Rate; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone